JP2022536494A5 - - Google Patents
Info
- Publication number
- JP2022536494A5 JP2022536494A5 JP2021573432A JP2021573432A JP2022536494A5 JP 2022536494 A5 JP2022536494 A5 JP 2022536494A5 JP 2021573432 A JP2021573432 A JP 2021573432A JP 2021573432 A JP2021573432 A JP 2021573432A JP 2022536494 A5 JP2022536494 A5 JP 2022536494A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pain
- composition
- pharmaceutical tablet
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962859443P | 2019-06-10 | 2019-06-10 | |
| US62/859,443 | 2019-06-10 | ||
| PCT/US2020/036767 WO2020251923A1 (en) | 2019-06-10 | 2020-06-09 | Treatment of abdominal pain associated with diarrhea-predominant irritable bowel syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022536494A JP2022536494A (ja) | 2022-08-17 |
| JP2022536494A5 true JP2022536494A5 (https=) | 2023-06-16 |
Family
ID=73782241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573432A Pending JP2022536494A (ja) | 2019-06-10 | 2020-06-09 | 下痢型過敏性腸症候群に関連する腹痛の処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20220241367A1 (https=) |
| EP (1) | EP3979992A4 (https=) |
| JP (1) | JP2022536494A (https=) |
| CN (2) | CN114206324A (https=) |
| CA (1) | CA3140528A1 (https=) |
| MA (1) | MA56128A (https=) |
| WO (1) | WO2020251923A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119185278A (zh) * | 2024-10-29 | 2024-12-27 | 鸿花(北京)科技有限公司 | L-茶氨酸在肠易激惹综合征的预防和治疗产品中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130059797A1 (en) * | 2009-11-03 | 2013-03-07 | Forest Laboratories Holdings Limited | Linaclotide for the Treatment of Chronic Constipation |
| EP2603232B1 (en) * | 2010-08-11 | 2019-09-25 | Ironwood Pharmaceuticals, Inc. | Stable formulations of linaclotide |
| CA2811001A1 (en) * | 2010-09-11 | 2012-03-15 | Ironwood Pharmaceuticals, Inc. | Treatment of constipation-predominant irritable bowel syndrome |
| MX347354B (es) * | 2011-08-17 | 2017-04-24 | Ironwood Pharmaceuticals Inc | Tratamientos para trastornos gastrointestinales. |
| UA119335C2 (uk) * | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Композиції лінаклотиду з затриманим вивільненням |
| EP3302440B1 (en) * | 2015-06-05 | 2021-01-06 | Ironwood Pharmaceuticals, Inc. | Modified or targeted release formulations of linaclotide |
| MX2019007574A (es) * | 2016-12-21 | 2019-09-04 | Ironwood Pharmaceuticals Inc | Metodos de tratamiento de sindrome de intestino irritable con formulaciones modificadas o de liberacion retardada de linaclotida. |
-
2020
- 2020-06-09 WO PCT/US2020/036767 patent/WO2020251923A1/en not_active Ceased
- 2020-06-09 CN CN202080056801.3A patent/CN114206324A/zh active Pending
- 2020-06-09 US US17/617,548 patent/US20220241367A1/en not_active Abandoned
- 2020-06-09 CA CA3140528A patent/CA3140528A1/en active Pending
- 2020-06-09 EP EP20822238.0A patent/EP3979992A4/en not_active Withdrawn
- 2020-06-09 CN CN202311831560.7A patent/CN118105461A/zh active Pending
- 2020-06-09 JP JP2021573432A patent/JP2022536494A/ja active Pending
- 2020-06-09 MA MA056128A patent/MA56128A/fr unknown
-
2022
- 2022-11-27 US US18/058,869 patent/US20230173016A1/en not_active Abandoned
-
2023
- 2023-07-13 US US18/351,740 patent/US20230346878A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5968300B2 (ja) | 高用量、水溶性及び吸湿性薬剤基質用の制御放出性剤形 | |
| JP7397239B2 (ja) | インターロイキン－２３受容体のペプチド阻害剤の組成物 | |
| JP2017504590A5 (https=) | ||
| CN109475510B (zh) | 普瑞巴林的延长释放剂型 | |
| TWI377938B (en) | Gaba analog prodrug sustained release oral dosage forms | |
| WO2009047801A1 (en) | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders | |
| JP2019123729A (ja) | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト | |
| EP3079669A1 (en) | Delayed release compositions of linaclotide | |
| JP2014501267A (ja) | メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法 | |
| EP3062776A1 (en) | A delayed release drug formulation | |
| WO2023150500A1 (en) | Peptide inhibitors of interleukin-23 receptor and pharmaceutical compositions thereof | |
| JP2022536494A5 (https=) | ||
| CN105025888B (zh) | 肠溶片 | |
| JP2021502382A (ja) | 経口リファマイシンｓｖ組成物 | |
| JP2022093472A (ja) | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 | |
| JP2020512292A5 (https=) | ||
| CN113382720B (zh) | 用于美沙拉嗪或其衍生物施用的固体口服药物组合物 | |
| JP2021001223A (ja) | リナクロチドの改変または標的放出製剤 | |
| US20230346878A1 (en) | Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome | |
| JP2022544239A5 (https=) | ||
| JP2018516937A5 (https=) | ||
| US11458104B1 (en) | Enteric coated tiopronin tablet | |
| WO2019132837A1 (en) | Solid oral pharmaceutical compositions of mesalazine | |
| US20230142270A1 (en) | Delayed Release Compositions of Linaclotide | |
| HK40092077A (zh) | 白介素-23受体的肽抑制剂的组合物 |